Regentis Biomaterials Secures Key Japan Patent for GelrinC Cartilage Treatment
July 20, 2026 — Regentis Biomaterials secures Japan patent for GelrinC's organic solvent-free manufacturing process, advancing cartilage repair treatment in Europe and U.S. trials.